NLRP3 and Cognitive impairment: (1) EA treatment improved cognitive impairment of POCD in aged mice; (2) EA treatment decreased neuroinflammation in mouse hippocampus; (3) EA treatment suppressed the activation of NLRP3 inflammasome; and (4) NLRP3 inflammasome is critical for the treatment effects of EA.